Zoetis Inc. (ZTS)
Largest Insider Buys in Sector
ZTS Stock Price History Chart
ZTS Stock Performance
About Zoetis Inc.
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company also offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives …
Insider Activity of Zoetis Inc.
Over the last 12 months, insiders at Zoetis Inc. have bought $0 and sold $6.92M worth of Zoetis Inc. stock.
On average, over the past 5 years, insiders at Zoetis Inc. have bought $2.5M and sold $78.66M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 15,180 shares for transaction amount of $2.5M was made by SCULLY ROBERT W (director) on 2021‑02‑19.
List of Insider Buy and Sell Transactions, Zoetis Inc.
| 2024-04-18 | Sale | Executive Vice President | 923 0.0002% | $151.17 | $139,530 | +16.86% | ||
| 2024-03-18 | Sale | Executive Vice President | 923 0.0002% | $173.33 | $159,984 | +2.92% | ||
| 2024-03-11 | Sale | director | 1,370 0.0003% | $182.68 | $250,265 | -4.40% | ||
| 2024-02-20 | Sale | Chief Executive Officer | 13,000 0.0028% | $187.20 | $2.43M | -5.19% | ||
| 2024-02-20 | Sale | Executive Vice President | 923 0.0002% | $187.30 | $172,878 | -5.19% | ||
| 2024-02-13 | Sale | Executive Vice President | 2,848 0.0006% | $186.86 | $532,177 | -3.11% | ||
| 2024-02-12 | Sale | Executive Vice President | 363 <0.0001% | $197.74 | $71,780 | -9.23% | ||
| 2024-01-18 | Sale | Executive Vice President | 923 0.0002% | $191.43 | $176,690 | -5.27% | ||
| 2023-12-18 | Sale | Executive Vice President | 923 0.0002% | $198.14 | $182,883 | -7.40% | ||
| 2023-12-14 | Sale | Executive Vice President | 2,500 0.0005% | $200.00 | $500,000 | -8.70% | ||
| 2023-11-21 | Sale | Chief Executive Officer | 13,000 0.0028% | $176.84 | $2.3M | +1.61% | ||
| 2023-11-17 | Sale | Executive Vice President | 923 0.0002% | $177.46 | $163,796 | +4.24% | ||
| 2023-10-18 | Sale | Executive Vice President | 923 0.0002% | $172.92 | $159,605 | +7.02% | ||
| 2023-09-18 | Sale | Executive Vice President | 923 0.0002% | $179.58 | $165,752 | -1.50% | ||
| 2023-09-15 | Sale | Executive Vice President | 9,905 0.0022% | $180.15 | $1.78M | -1.85% | ||
| 2023-09-01 | Sale | Executive Vice President | 923 0.0002% | $192.97 | $178,111 | -8.10% | ||
| 2023-08-22 | Sale | Chief Executive Officer | 13,000 0.0028% | $179.97 | $2.34M | -2.67% | ||
| 2023-08-09 | Sale | Executive Vice President | 1,179 0.0003% | $189.94 | $223,939 | -5.93% | ||
| 2023-05-23 | Sale | Chief Executive Officer | 13,000 0.0029% | $176.56 | $2.3M | +2.02% | ||
| 2023-04-18 | Sale | Executive Vice President | 4,338 0.0009% | $175.94 | $763,228 | +2.93% |
Insider Historical Profitability
| Lagano Roxanne | Executive Vice President | 14800 0.0033% | $176.40 | 1 | 39 | +3.04% |
| Pershing Square Capital Management, L.P. | director | 24973145 5.5353% | $176.40 | 1 | 2 | <0.0001% |
| Knupp Catherine A. | Executive Vice President | 43642 0.0097% | $176.40 | 1 | 8 | +3.04% |
| Lewis Clinton A. Jr. | Executive Vice President | 27904 0.0062% | $176.40 | 1 | 12 | +3.04% |
| Chen Heidi C. | Executive Vice President | 27478 0.0061% | $176.40 | 1 | 27 | +3.04% |
Institutional Investor Ownership
| The Vanguard Group | $6.9B | 8.93 | 40.75M | +1.03% | +$70.16M | 0.13 | |
| BlackRock | $6.22B | 8.05 | 36.73M | +0.65% | +$40.19M | 0.14 | |
| State Street | $3.31B | 4.29 | 19.57M | +1.28% | +$41.93M | 0.14 | |
| State Farm | $2.73B | 3.54 | 16.15M | -1.18% | -$32.69M | 2.46 | |
| Bank of America | $2.36B | 3.06 | 13.96M | +3.39% | +$77.38M | 0.23 |